93 related articles for article (PubMed ID: 30732868)
1. High serum arsenic and cardiovascular risk factors in patients undergoing continuous ambulatory peritoneal dialysis.
Xiang S; Jin Q; Xu F; Yao Y; Liang W; Zuo X; Ye T; Ying C
J Trace Elem Med Biol; 2019 Mar; 52():1-5. PubMed ID: 30732868
[TBL] [Abstract][Full Text] [Related]
2. Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis patients.
Chen T; Yang M
Int Immunopharmacol; 2020 Jan; 78():106063. PubMed ID: 31835088
[TBL] [Abstract][Full Text] [Related]
3. Comparative Study on Trace Element Excretions between Nonanuric and Anuric Patients Undergoing Continuous Ambulatory Peritoneal Dialysis.
Xiang S; Yao Y; Wan Y; Liang W; Meng R; Jin Q; Wu N; Xu F; Ying C; Zuo X
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27999390
[TBL] [Abstract][Full Text] [Related]
4. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.
Su X; Zhang K; Guo F; Yuan B; Wang C; Xiao L; Wang J; Huang H
Clin Biochem; 2013 Oct; 46(15):1410-3. PubMed ID: 23796881
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for cardio-cerebrovascular events among patients undergoing continuous ambulatory peritoneal dialysis and their association with serum magnesium.
Li P; Lv T; Xu L; Yu W; Lu Y; Li Y; Hao J
Ren Fail; 2024 Dec; 46(1):2355354. PubMed ID: 38785302
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: A cross-sectional study.
Yin X; Zhang F; Shi Y
Front Med (Lausanne); 2023; 10():1142013. PubMed ID: 37122336
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
Hampson G; Vaja S; Evans C; Chesters CA; Pettit R; Evans W; Thomas D; Seed PT; Fraser WD
Nephron; 2002 May; 91(1):94-102. PubMed ID: 12021525
[TBL] [Abstract][Full Text] [Related]
8. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
Dong J; Wang H; Wang M
J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
Babazono T; Miyamae M; Tomonaga O; Omori Y
Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
[TBL] [Abstract][Full Text] [Related]
11. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
Wang AY; Woo J; Sea MM; Law MC; Lui SF; Li PK
Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
[TBL] [Abstract][Full Text] [Related]
12. Leptin in CAPD patients: serum concentrations and peritoneal loss.
Kagan A; Haran N; Leschinsky L; Shuali N; Rapoport J
Nephrol Dial Transplant; 1999 Feb; 14(2):400-5. PubMed ID: 10069196
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
14. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
[TBL] [Abstract][Full Text] [Related]
15. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
16. Associations of pulmonary function with serum biomarkers and dialysis adequacy in patients undergoing peritoneal dialysis.
Zhang P; Wu HM; Shen QY; Liu RY; Qi XM
Clin Exp Nephrol; 2016 Dec; 20(6):951-959. PubMed ID: 26868146
[TBL] [Abstract][Full Text] [Related]
17. Study of arsenic-protein binding in serum of patients on continuous ambulatory peritoneal dialysis.
Zhang X; Cornelis R; de Kimpe J; Mees L; Lameire N
Clin Chem; 1998 Jan; 44(1):141-7. PubMed ID: 9550571
[TBL] [Abstract][Full Text] [Related]
18. Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients?
Avram MM; Sreedhara R; Patel N; Chattopadhyay J; Thu T; Fein P
Adv Perit Dial; 1996; 12():266-71. PubMed ID: 8865917
[TBL] [Abstract][Full Text] [Related]
19. Sexual Dysfunction Reduction in Female Patients with Chronic Kidney Disease Undergoing Continuous Ambulatory Peritoneal Dialysis.
Duarsa GWK; Kandarini Y; Luciana L; Pramana IBP; Wirata G; Tirtayasa PMW; Yudiana IW; Santosa KB; Oka AAG
Acta Med Indones; 2020 Oct; 52(4):360-365. PubMed ID: 33377881
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for pulmonary arterial hypertension in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis.
Zhang L; Zhao S; Ma J; Gong J; Qiu G; Ren Y; Zen Y; Shi Y
Ren Fail; 2016 Jun; 38(5):815-21. PubMed ID: 26888091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
